FOSPHENYTOIN SODIUM

FOSPHENYTOIN SODIUM was reported 2585 times

FOSPHENYTOIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPILEPSY OF INFANCY WITH MIGRATING FOCAL SEIZURES 6 0.7500
1 ATYPICAL ABSENCE SEIZURE 1 0.2500
2 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 6 0.1935
3 CEREBELLAR MUTISM 1 0.1250
4 ACQUIRED MACROGLOSSIA 11 0.1236
5 CATHETER SITE DEHISCENCE 1 0.1111
6 MYOCARDIAL DEPRESSION 28 0.1085
7 PURPLE GLOVE SYNDROME 12 0.0916
8 OROPHARYNGEAL OEDEMA 13 0.0897
9 ACUTE ENCEPHALITIS WITH REFRACTORY, REPETITIVE PARTIAL SEIZURES 1 0.0714
10 CALCIUM PHOSPHATE PRODUCT INCREASED 1 0.0667
11 ATRIAL STANDSTILL 1 0.0667
12 ACQUIRED METHAEMOGLOBINAEMIA 2 0.0455
13 CHILD MALTREATMENT SYNDROME 1 0.0417
14 MACROGLOSSIA 22 0.0400
15 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 1 0.0370
16 ADENOVIRAL UPPER RESPIRATORY INFECTION 1 0.0345
17 CIRCUMSTANTIALITY 1 0.0333
18 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 24 0.0319
19 HYPERPLASIA ADRENAL 2 0.0317
20 MULTIPLE-DRUG RESISTANCE 97 0.0312
21 PROPOFOL INFUSION SYNDROME 21 0.0298
22 DECORTICATE POSTURE 3 0.0268
23 LARYNGEAL STENOSIS 15 0.0260
24 MULTISYSTEM INFLAMMATORY SYNDROME 4 0.0231
25 CEREBRAL ATAXIA 1 0.0227
26 ANALGESIC DRUG LEVEL DECREASED 1 0.0227
27 MYOTONIA 5 0.0225
28 CARDIAC ARREST NEONATAL 3 0.0217
29 PLATELET TOXICITY 2 0.0217
30 BLOOD ANTIDIURETIC HORMONE INCREASED 2 0.0215
31 NECROTISING COLITIS 27 0.0213
32 NECROTISING ENTEROCOLITIS NEONATAL 8 0.0197
33 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 9 0.0185
34 CEREBROSCLEROSIS 1 0.0179
35 INTERLEUKIN-2 RECEPTOR INCREASED 3 0.0175
36 CORTICAL VISUAL IMPAIRMENT 1 0.0172
37 ANTICONVULSANT DRUG LEVEL ABNORMAL 3 0.0170
38 CORTICAL DYSPLASIA 1 0.0169
39 CEREBRAL DYSGENESIS 1 0.0167
40 NEUROSURGERY 3 0.0162
41 ABDOMINAL COMPARTMENT SYNDROME 10 0.0157
42 HIPPOCAMPAL SCLEROSIS 2 0.0156
43 ACINETOBACTER SEPSIS 1 0.0156
44 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 10 0.0154
45 STATUS EPILEPTICUS 170 0.0150
46 CARDIOACTIVE DRUG LEVEL BELOW THERAPEUTIC 1 0.0147
47 LIMBIC ENCEPHALITIS 4 0.0145
48 EPILEPTIC ENCEPHALOPATHY 3 0.0135
49 PROTEUS TEST POSITIVE 3 0.0134
50 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
51 BLOOD CARBON MONOXIDE INCREASED 1 0.0123
52 BLOOD LACTATE DEHYDROGENASE 1 0.0123
53 COMA HEPATIC 9 0.0121
54 NEONATAL RESPIRATORY DEPRESSION 4 0.0120
55 PHLEBOLITH 2 0.0118
56 ACUTE VESTIBULAR SYNDROME 1 0.0118
57 AORTIC BRUIT 1 0.0104
58 BRAIN TUMOUR OPERATION 2 0.0100
59 CAPILLARY NAIL REFILL TEST ABNORMAL 1 0.0096
60 VENTRICULAR FAILURE 3 0.0096
61 IMMOBILISATION SYNDROME 2 0.0094
62 MELAS SYNDROME 2 0.0093
63 ANTICONVULSANT DRUG LEVEL INCREASED 14 0.0087
64 MYOCLONIC EPILEPSY 13 0.0086
65 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 4 0.0085
66 DEVICE INTERACTION 2 0.0084
67 CALCIUM IONISED DECREASED 2 0.0082
68 BURKHOLDERIA TEST POSITIVE 1 0.0081
69 CALCIFICATION OF MUSCLE 1 0.0080
70 SKIN DESQUAMATION 2 0.0079
71 ASPIRATION BONE MARROW ABNORMAL 1 0.0074
72 DEVELOPMENTAL REGRESSION 1 0.0074
73 SINUS ARREST 11 0.0070
74 ACIDOSIS HYPERCHLORAEMIC 4 0.0067
75 RETINOPATHY HYPERTENSIVE 2 0.0066
76 TRACHEITIS 5 0.0066
77 VAGAL NERVE STIMULATOR IMPLANTATION 2 0.0065
78 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
79 CONFUSIONAL AROUSAL 1 0.0062
80 ANAPLASTIC ASTROCYTOMA 1 0.0061
81 HYPERCREATINAEMIA 2 0.0060
82 NODAL ARRHYTHMIA 5 0.0058
83 METASTASES TO CHEST WALL 2 0.0058
84 TACHYPHYLAXIS 2 0.0057
85 TRANSVERSE SINUS THROMBOSIS 3 0.0057
86 ANTICONVULSANT DRUG LEVEL DECREASED 8 0.0057
87 ACUTE HEPATITIS C 1 0.0055
88 ENCEPHALOMALACIA 3 0.0053
89 FOCAL DYSCOGNITIVE SEIZURES 6 0.0053
90 LABORATORY TEST INTERFERENCE 4 0.0051
91 VENTRICULAR DYSFUNCTION 13 0.0050
92 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
93 BONE FORMATION INCREASED 1 0.0049
94 NYSTAGMUS 26 0.0049
95 PYRAMIDAL TRACT SYNDROME 2 0.0048
96 CEREBRAL HAEMORRHAGE NEONATAL 1 0.0047
97 INTRACRANIAL VENOUS SINUS THROMBOSIS 5 0.0047
98 GLIOSIS 2 0.0047
99 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0046
100 PRODUCT NAME CONFUSION 5 0.0046
101 PNEUMATOSIS 2 0.0045
102 CHOREOATHETOSIS 3 0.0044
103 PRODUCT APPEARANCE CONFUSION 4 0.0043
104 HAEMODYNAMIC INSTABILITY 33 0.0043
105 BILIRUBIN CONJUGATED INCREASED 10 0.0043
106 BONE MARROW NECROSIS 1 0.0043
107 TONIC CONVULSION 6 0.0042
108 PARTIAL SEIZURES 22 0.0042
109 CLONIC CONVULSION 3 0.0041
110 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
111 RESPIRATORY ACIDOSIS 16 0.0041
112 HISTIOCYTOSIS HAEMATOPHAGIC 12 0.0040
113 HYPERNATRAEMIA 20 0.0040
114 DRUG LABEL CONFUSION 1 0.0040
115 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 7 0.0040
116 DANDY-WALKER SYNDROME 1 0.0039
117 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
118 SUPERIOR SAGITTAL SINUS THROMBOSIS 3 0.0038
119 ANAEMIA HAEMOLYTIC AUTOIMMUNE 3 0.0036
120 CONTRAST ENCEPHALOPATHY 1 0.0036
121 APNOEIC ATTACK 2 0.0035
122 RESPIRATORY SYMPTOM 10 0.0035
123 ELECTROENCEPHALOGRAM ABNORMAL 11 0.0035
124 ENANTHEMA 2 0.0035
125 NODAL RHYTHM 5 0.0034
126 DOSE CALCULATION ERROR 2 0.0034
127 CEREBELLAR ATROPHY 3 0.0034
128 DEVICE COMPUTER ISSUE 1 0.0033
129 BRADYPNOEA 9 0.0033
130 SELECTIVE EATING DISORDER 3 0.0033
131 SINUS NODE DYSFUNCTION 6 0.0033
132 CONTRAST MEDIA DEPOSITION 1 0.0032
133 ATRIOVENTRICULAR BLOCK 24 0.0031
134 CNS VENTRICULITIS 1 0.0031
135 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
136 PYURIA 3 0.0030
137 ARRHYTHMIC STORM 1 0.0030
138 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
139 RESPIRATORY DEPRESSION 36 0.0029
140 ISCHAEMIC HEPATITIS 4 0.0029
141 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 1 0.0029
142 HYPERAMMONAEMIC ENCEPHALOPATHY 5 0.0029
143 PULMONARY VENO-OCCLUSIVE DISEASE 2 0.0029
144 HAEMORRHAGIC CEREBRAL INFARCTION 2 0.0028
145 ANOXIA 1 0.0028
146 STEVENS-JOHNSON SYNDROME 62 0.0028
147 IMMUNISATION REACTION 2 0.0028
148 INFUSION SITE MASS 3 0.0028
149 LIP EROSION 2 0.0027
150 BRAIN CONTUSION 2 0.0027
151 INFUSION SITE EXTRAVASATION 17 0.0027
152 BRAIN STEM SYNDROME 2 0.0027
153 MULTIPLE DRUG THERAPY 2 0.0027
154 INTELLECTUAL DISABILITY 4 0.0026
155 ASTROCYTOMA 1 0.0025
156 ESCHERICHIA TEST POSITIVE 3 0.0025
157 ELECTROMECHANICAL DISSOCIATION 2 0.0025
158 BRAIN COMPRESSION 1 0.0025
159 DIABETES INSIPIDUS 6 0.0025
160 CAT SCRATCH DISEASE 1 0.0025
161 SIMPLE PARTIAL SEIZURES 2 0.0025
162 KETONURIA 2 0.0025
163 CARDIAC VENTRICULAR DISORDER 1 0.0024
164 SEIZURE CLUSTER 2 0.0024
165 BRAIN ABSCESS 6 0.0024
166 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
167 AMMONIA INCREASED 12 0.0023
168 METABOLIC ENCEPHALOPATHY 7 0.0023
169 TOXIC EPIDERMAL NECROLYSIS 35 0.0023
170 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
171 ENCEPHALITIS AUTOIMMUNE 3 0.0023
172 CANDIDA SEPSIS 2 0.0022
173 DRUG LEVEL ABOVE THERAPEUTIC 10 0.0022
174 VASOSPASM 2 0.0022
175 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
176 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
177 ENDOTRACHEAL INTUBATION 6 0.0021
178 AIR EMBOLISM 1 0.0021
179 VASCULAR PAIN 2 0.0021
180 BLOOD LACTIC ACID INCREASED 11 0.0021
181 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
182 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
183 EPIDERMAL NECROSIS 2 0.0021
184 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
185 HYPERTHERMIA MALIGNANT 3 0.0020
186 CSF TEST ABNORMAL 1 0.0020
187 CONGENITAL HYDROCEPHALUS 1 0.0020
188 BLOOD ALBUMIN ABNORMAL 1 0.0019
189 BRAIN MIDLINE SHIFT 1 0.0019
190 CONVULSION NEONATAL 1 0.0019
191 BEHAVIOUR DISORDER 10 0.0018
192 BRADYARRHYTHMIA 3 0.0018
193 DRUG EFFECT PROLONGED 1 0.0018
194 CYTOLYTIC HEPATITIS 6 0.0018
195 BLOOD PH INCREASED 1 0.0018
196 RASH MORBILLIFORM 5 0.0018
197 COMPLEX PARTIAL SEIZURES 2 0.0018
198 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
199 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 98 0.0018
200 CEREBRAL ATROPHY 7 0.0018
201 BLOOD PH DECREASED 3 0.0018
202 DRUG ERUPTION 31 0.0017
203 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
204 STREPTOCOCCAL SEPSIS 2 0.0017
205 JUGULAR VEIN THROMBOSIS 3 0.0017
206 HEPATITIS FULMINANT 5 0.0017
207 DYSMETRIA 1 0.0017
208 VESTIBULAR DISORDER 2 0.0016
209 ERYTHEMA MULTIFORME 15 0.0016
210 BRADYCARDIA NEONATAL 2 0.0016
211 TRISOMY 21 2 0.0016
212 DRY GANGRENE 1 0.0016
213 CYANOSIS NEONATAL 1 0.0016
214 ANOXIC ENCEPHALOPATHY 1 0.0016
215 IATROGENIC INJURY 2 0.0016
216 CHANGE IN SEIZURE PRESENTATION 1 0.0015
217 VITAMIN D DEFICIENCY 15 0.0015
218 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
219 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0015
220 DRUG CLEARANCE DECREASED 2 0.0015
221 ANISOCYTOSIS 1 0.0015
222 DELIVERY 1 0.0015
223 GRAND MAL CONVULSION 14 0.0015
224 CELL DEATH 3 0.0015
225 ENCEPHALOPATHY 37 0.0015
226 EPILEPSY 46 0.0015
227 STENOTROPHOMONAS INFECTION 2 0.0015
228 MENINGITIS VIRAL 2 0.0015
229 TONGUE BITING 3 0.0015
230 VENTRICULAR TACHYCARDIA 24 0.0015
231 RHONCHI 2 0.0014
232 ENCEPHALITIS 10 0.0014
233 CARDIAC ARREST 119 0.0014
234 FOETAL DISTRESS SYNDROME 3 0.0014
235 APNOEA 11 0.0014
236 TRACHEOSTOMY 2 0.0014
237 MENINGITIS BACTERIAL 2 0.0014
238 BRONCHIAL WALL THICKENING 1 0.0014
239 BITE 1 0.0014
240 AMNIOTIC CAVITY INFECTION 1 0.0014
241 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
242 APALLIC SYNDROME 1 0.0014
243 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
244 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
245 EXCESSIVE EYE BLINKING 2 0.0014
246 INTERCEPTED DRUG DISPENSING ERROR 2 0.0013
247 SEIZURE 155 0.0013
248 HEPATIC NECROSIS 5 0.0013
249 DISTRIBUTIVE SHOCK 3 0.0013
250 ASTIGMATISM 2 0.0013
251 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
252 COAGULATION TEST ABNORMAL 1 0.0013
253 ELECTROLYTE IMBALANCE 15 0.0013
254 GASTROSTOMY 2 0.0013
255 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
256 BRAIN OEDEMA 16 0.0013
257 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
258 HYPERBILIRUBINAEMIA 13 0.0013
259 CARDIOGENIC SHOCK 18 0.0013
260 GRAFT VERSUS HOST DISEASE 9 0.0013
261 RHABDOMYOLYSIS 52 0.0012
262 PULSE ABNORMAL 3 0.0012
263 PRODUCT PACKAGING CONFUSION 3 0.0012
264 BASAL GANGLIA HAEMORRHAGE 1 0.0012
265 EXTRAVASATION 5 0.0012
266 COLLAPSE OF LUNG 1 0.0012
267 RESUSCITATION 2 0.0012
268 BRADYCARDIA 64 0.0012
269 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
270 ENTEROBACTER INFECTION 2 0.0012
271 EXPOSURE VIA INGESTION 3 0.0012
272 URINARY TRACT INFECTION BACTERIAL 3 0.0012
273 SALMONELLOSIS 2 0.0012
274 DRUG LEVEL DECREASED 12 0.0012
275 GAZE PALSY 2 0.0012
276 PHLEBITIS 6 0.0012
277 ATONIC SEIZURES 1 0.0012
278 HYPOPNOEA 4 0.0012
279 ARTERIAL STENOSIS 1 0.0011
280 DRUG LEVEL FLUCTUATING 1 0.0011
281 AREFLEXIA 3 0.0011
282 BLOOD ALBUMIN INCREASED 1 0.0011
283 WHITE BLOOD CELL DISORDER 3 0.0011
284 DERMATITIS BULLOUS 8 0.0011
285 BACTERAEMIA 13 0.0011
286 MYOCLONUS 13 0.0011
287 PUPILLARY REFLEX IMPAIRED 2 0.0011
288 CARDIAC DYSFUNCTION 4 0.0011
289 CONVULSION 61 0.0011
290 BRAIN STEM HAEMORRHAGE 1 0.0011
291 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
292 CEREBRAL PALSY 1 0.0011
293 PULSE ABSENT 5 0.0011
294 UNRESPONSIVE TO STIMULI 27 0.0010
295 CEREBELLAR ATAXIA 1 0.0010
296 HYPOREFLEXIA 2 0.0010
297 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
298 ACUTE RESPIRATORY FAILURE 20 0.0010
299 COMA SCALE ABNORMAL 3 0.0010
300 HEPATIC FUNCTION ABNORMAL 38 0.0010
301 ATAXIA 12 0.0010
302 BRAIN HERNIATION 3 0.0010
303 HYPOCALCAEMIA 19 0.0010
304 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
305 METABOLIC ACIDOSIS 32 0.0010
306 CANDIDIASIS 4 0.0010
307 BRAIN HYPOXIA 1 0.0010
308 CATHETER RELATED INFECTION 1 0.0010
309 BRAIN STEM INFARCTION 1 0.0010
310 QUADRIPLEGIA 2 0.0010
311 CONSCIOUSNESS FLUCTUATING 1 0.0010
312 RESPIRATORY RATE DECREASED 3 0.0010
313 HAEMODIALYSIS 8 0.0010
314 URINARY BLADDER HAEMORRHAGE 2 0.0009
315 SCREAMING 6 0.0009
316 CIRCULATORY COLLAPSE 16 0.0009
317 SKIN EROSION 3 0.0009
318 HYPERPHOSPHATAEMIA 2 0.0009
319 MULTI-ORGAN FAILURE 16 0.0009
320 DELIRIUM 32 0.0009
321 RENAL TUBULAR ACIDOSIS 2 0.0009
322 ACINETOBACTER INFECTION 1 0.0009
323 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
324 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
325 INTESTINAL ISCHAEMIA 5 0.0009
326 DRUG LEVEL INCREASED 15 0.0009
327 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
328 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
329 ILEUS PARALYTIC 4 0.0009
330 PSEUDOMEMBRANOUS COLITIS 2 0.0009
331 BK VIRUS INFECTION 3 0.0009
332 CATHETER RELATED COMPLICATION 1 0.0009
333 WRONG PRODUCT ADMINISTERED 6 0.0009
334 HEMIPARESIS 15 0.0009
335 LICHENOID KERATOSIS 2 0.0009
336 CARBON DIOXIDE DECREASED 1 0.0009
337 CEREBRAL VENTRICLE DILATATION 1 0.0009
338 NEUROLOGICAL DECOMPENSATION 2 0.0009
339 MENTAL STATUS CHANGES 24 0.0009
340 PRODUCT LABEL CONFUSION 5 0.0009
341 SUBDURAL HAEMATOMA 12 0.0008
342 SLOW SPEECH 2 0.0008
343 CEREBRAL ARTERY EMBOLISM 1 0.0008
344 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
345 OLIGURIA 5 0.0008
346 BLOOD UREA DECREASED 1 0.0008
347 SEDATION 21 0.0008
348 GASTROINTESTINAL TUBE INSERTION 2 0.0008
349 HYPOTONIA 8 0.0008
350 URINE OUTPUT DECREASED 7 0.0008
351 HYPERAMMONAEMIA 4 0.0008
352 BRAIN INJURY 8 0.0008
353 SYSTEMIC CANDIDA 2 0.0008
354 HEPATIC FAILURE 24 0.0008
355 HYPOTHERMIA 8 0.0008
356 HYPERTHERMIA 6 0.0008
357 ACIDOSIS 6 0.0008
358 CARDIOTOXICITY 7 0.0008
359 CARDIO-RESPIRATORY ARREST 32 0.0008
360 EXPOSURE VIA BREAST MILK 3 0.0008
361 ANION GAP INCREASED 1 0.0007
362 DRUG RESISTANCE 19 0.0007
363 HYDROCEPHALUS 4 0.0007
364 CLONUS 2 0.0007
365 ACCIDENTAL POISONING 1 0.0007
366 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
367 BILIARY TRACT DISORDER 1 0.0007
368 PNEUMONIA ASPIRATION 18 0.0007
369 CULTURE URINE POSITIVE 1 0.0007
370 BUNDLE BRANCH BLOCK LEFT 3 0.0007
371 CEREBRAL THROMBOSIS 2 0.0007
372 HEPATIC CYTOLYSIS 9 0.0007
373 AUDITORY DISORDER 1 0.0007
374 GENERALISED ERYTHEMA 4 0.0007
375 PNEUMATOSIS INTESTINALIS 2 0.0007
376 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
377 RESPIRATORY ARREST 19 0.0007
378 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
379 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
380 SEROTONIN SYNDROME 13 0.0007
381 COMA 32 0.0007
382 THERAPY NON-RESPONDER 30 0.0007
383 CEREBROVASCULAR DISORDER 2 0.0007
384 COAGULOPATHY 11 0.0007
385 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
386 CEREBRAL INFARCTION 16 0.0007
387 CHEST X-RAY ABNORMAL 2 0.0007
388 TREATMENT FAILURE 54 0.0007
389 CALCULUS URINARY 1 0.0006
390 BRAIN DEATH 2 0.0006
391 RESPIRATORY FAILURE 47 0.0006
392 ILEUS 8 0.0006
393 BACTERIAL VAGINOSIS 1 0.0006
394 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
395 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
396 SINUS TACHYCARDIA 9 0.0006
397 EOSINOPHILIA 11 0.0006
398 THROMBOTIC MICROANGIOPATHY 6 0.0006
399 RENAL TUBULAR NECROSIS 6 0.0006
400 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
401 HYPOGAMMAGLOBULINAEMIA 4 0.0006
402 HEMIPLEGIA 5 0.0006
403 THERAPEUTIC AGENT TOXICITY 2 0.0006
404 MENINGITIS 4 0.0006
405 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
406 DRUG INTERACTION 94 0.0006
407 WOUND DEHISCENCE 2 0.0006
408 CEREBELLAR INFARCTION 1 0.0006
409 DYSLIPIDAEMIA 3 0.0006
410 DIABETIC RETINOPATHY 2 0.0006
411 ENDOCARDITIS 3 0.0006
412 BLOOD AMYLASE INCREASED 1 0.0006
413 HYPOTENSION 117 0.0006
414 CERVICAL SPINAL STENOSIS 1 0.0006
415 BLOOD CHLORIDE INCREASED 1 0.0006
416 SKIN NECROSIS 3 0.0006
417 COGNITIVE DISORDER 27 0.0006
418 FAILURE TO THRIVE 3 0.0006
419 DRUG-INDUCED LIVER INJURY 18 0.0006
420 NEUROTOXICITY 10 0.0006
421 SERUM FERRITIN INCREASED 3 0.0006
422 HYPOXIA 20 0.0006
423 GENERALISED OEDEMA 7 0.0006
424 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
425 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
426 CONJUNCTIVAL HYPERAEMIA 2 0.0006
427 BLOOD PRESSURE DECREASED 37 0.0006
428 DEVELOPMENTAL DELAY 5 0.0006
429 LIVER TRANSPLANT 2 0.0005
430 RASH PUSTULAR 4 0.0005
431 ASPIRATION 6 0.0005
432 VENTRICULAR ARRHYTHMIA 2 0.0005
433 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
434 CONDUCTION DISORDER 1 0.0005
435 DISORGANISED SPEECH 1 0.0005
436 IRON DEFICIENCY ANAEMIA 5 0.0005
437 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
438 NECROSIS 3 0.0005
439 INTRACRANIAL PRESSURE INCREASED 3 0.0005
440 REBOUND EFFECT 6 0.0005
441 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
442 CHOLECYSTITIS ACUTE 3 0.0005
443 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
444 NEUROLOGICAL SYMPTOM 3 0.0005
445 RENAL FAILURE CHRONIC 4 0.0005
446 RENAL FAILURE ACUTE 22 0.0005
447 BLOOD BILIRUBIN INCREASED 14 0.0005
448 HAEMOLYSIS 4 0.0005
449 AGITATION 38 0.0005
450 SINUS BRADYCARDIA 5 0.0005
451 RALES 3 0.0005
452 CARDIOPULMONARY FAILURE 2 0.0005
453 APLASIA 1 0.0005
454 WOUND SECRETION 2 0.0005
455 BICYTOPENIA 1 0.0005
456 TORSADE DE POINTES 4 0.0005
457 PNEUMONIA FUNGAL 2 0.0005
458 TACHYCARDIA 45 0.0005
459 BLOOD ALBUMIN DECREASED 4 0.0005
460 LOW BIRTH WEIGHT BABY 4 0.0005
461 TOXICITY TO VARIOUS AGENTS 84 0.0005
462 SKIN REACTION 7 0.0005
463 CYSTITIS HAEMORRHAGIC 2 0.0005
464 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
465 NO THERAPEUTIC RESPONSE 6 0.0005
466 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
467 SUBARACHNOID HAEMORRHAGE 5 0.0005
468 MEDICATION ERROR 27 0.0005
469 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
470 ATRIAL THROMBOSIS 1 0.0005
471 CAPILLARY LEAK SYNDROME 1 0.0005
472 SOCIAL PROBLEM 2 0.0005
473 SHOCK 11 0.0005
474 INFUSION SITE SWELLING 3 0.0005
475 BLEPHAROSPASM 3 0.0005
476 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
477 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
478 CARDIAC FAILURE CHRONIC 2 0.0005
479 ACCIDENTAL OVERDOSE 17 0.0005
480 APHASIA 14 0.0005
481 LACTIC ACIDOSIS 15 0.0005
482 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
483 LUNG INFILTRATION 4 0.0005
484 CARDIAC FAILURE ACUTE 3 0.0004
485 RHINITIS ALLERGIC 2 0.0004
486 THERAPY PARTIAL RESPONDER 7 0.0004
487 BACTERIAL TEST POSITIVE 1 0.0004
488 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
489 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
490 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
491 SEPTIC SHOCK 19 0.0004
492 RESPIRATORY DISTRESS 12 0.0004
493 PAPULE 3 0.0004
494 CHOLESTASIS 8 0.0004
495 DRUG INEFFECTIVE 546 0.0004
496 ATELECTASIS 4 0.0004
497 ENTEROCOCCAL INFECTION 2 0.0004
498 MOUTH HAEMORRHAGE 3 0.0004
499 CARDIOMEGALY 5 0.0004
500 CARDIOMYOPATHY 6 0.0004
501 DENTAL OPERATION 1 0.0004
502 STAPHYLOCOCCAL SEPSIS 2 0.0004
503 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
504 HAEMORRHAGE INTRACRANIAL 6 0.0004
505 ARRHYTHMIA 19 0.0004
506 DERMATITIS EXFOLIATIVE 2 0.0004
507 TOXIC SKIN ERUPTION 4 0.0004
508 STAPHYLOCOCCAL INFECTION 13 0.0004
509 APPENDICITIS PERFORATED 1 0.0004
510 CEREBRAL ISCHAEMIA 2 0.0004
511 RASH GENERALISED 10 0.0004
512 HYPOALBUMINAEMIA 3 0.0004
513 ANGIOEDEMA 17 0.0004
514 TREATMENT NONCOMPLIANCE 21 0.0004
515 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
516 PREMATURE DELIVERY 6 0.0004
517 ERYTHEMA OF EYELID 2 0.0004
518 ABDOMINAL RIGIDITY 1 0.0004
519 NORMAL NEWBORN 2 0.0004
520 THROMBOCYTOPENIA 41 0.0004
521 BLOOD PHOSPHORUS INCREASED 1 0.0004
522 PREMATURE BABY 11 0.0004
523 CEREBRAL HAEMORRHAGE 13 0.0004
524 DEAFNESS UNILATERAL 2 0.0004
525 DRUG SCREEN FALSE POSITIVE 1 0.0004
526 VENTRICULAR FIBRILLATION 4 0.0004
527 MALNUTRITION 4 0.0004
528 PREMATURE LABOUR 2 0.0004
529 INADEQUATE ANALGESIA 3 0.0004
530 DIALYSIS 5 0.0004
531 PERONEAL NERVE PALSY 2 0.0004
532 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
533 VISUAL DISTURBANCE 2 0.0003
534 DYSKINESIA 14 0.0003
535 METABOLIC DISORDER 2 0.0003
536 FLUID OVERLOAD 5 0.0003
537 HYPERTRIGLYCERIDAEMIA 2 0.0003
538 SPLENOMEGALY 4 0.0003
539 DECREASED INTEREST 2 0.0003
540 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
541 BLISTER 19 0.0003
542 EXPOSURE DURING PREGNANCY 21 0.0003
543 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
544 LEUKOCYTOSIS 6 0.0003
545 BONE MARROW DISORDER 1 0.0003
546 OSTEOPENIA 5 0.0003
547 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
548 BRAIN NEOPLASM 3 0.0003
549 DYSAESTHESIA 1 0.0003
550 DEVICE RELATED INFECTION 5 0.0003
551 HYPONATRAEMIA 18 0.0003
552 LACERATION 3 0.0003
553 POISONING 4 0.0003
554 MULTIPLE INJURIES 2 0.0003
555 PHOTOPSIA 2 0.0003
556 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
557 OFF LABEL USE 274 0.0003
558 ENTERITIS 2 0.0003
559 CUSHINGOID 1 0.0003
560 PROCTALGIA 2 0.0003
561 BACTERIAL SEPSIS 1 0.0003
562 PRODUCT PREPARATION ISSUE 2 0.0003
563 PANCYTOPENIA 17 0.0003
564 DEAFNESS NEUROSENSORY 1 0.0003
565 RESTLESSNESS 11 0.0003
566 BLOOD UREA INCREASED 5 0.0003
567 CEREBRAL HAEMATOMA 1 0.0003
568 AKATHISIA 4 0.0003
569 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
570 SCAR 5 0.0003
571 RESPIRATION ABNORMAL 2 0.0003
572 DROOLING 2 0.0003
573 VENTRICULAR EXTRASYSTOLES 3 0.0003
574 PETECHIAE 3 0.0003
575 FORMICATION 2 0.0003
576 EXTRASYSTOLES 2 0.0003
577 HYPERKALAEMIA 10 0.0003
578 APPLICATION SITE REACTION 2 0.0003
579 SUDDEN DEATH 3 0.0003
580 DUODENAL ULCER 2 0.0003
581 HYPOKALAEMIA 13 0.0003
582 BONE LESION 1 0.0003
583 TONGUE DISORDER 2 0.0003
584 AMYLASE INCREASED 1 0.0003
585 LIVER DISORDER 12 0.0003
586 CEREBRAL DISORDER 2 0.0003
587 RASH MACULO-PAPULAR 6 0.0003
588 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
589 FEELING DRUNK 2 0.0003
590 BLOOD CALCIUM DECREASED 3 0.0003
591 HEPATIC ENZYME INCREASED 18 0.0003
592 COMMUNICATION DISORDER 1 0.0003
593 LETHARGY 15 0.0003
594 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
595 POST PROCEDURAL COMPLICATION 5 0.0003
596 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
597 RENAL FAILURE 34 0.0003
598 DRUG SCREEN POSITIVE 2 0.0003
599 HAEMATOCRIT DECREASED 5 0.0003
600 HYPERLIPIDAEMIA 3 0.0003
601 AZOTAEMIA 1 0.0003
602 RENAL IMPAIRMENT 21 0.0002
603 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
604 SENSORY LOSS 2 0.0002
605 DECUBITUS ULCER 2 0.0002
606 ASPHYXIA 2 0.0002
607 LIVER INJURY 6 0.0002
608 ESCHERICHIA INFECTION 2 0.0002
609 ANAPHYLACTOID REACTION 1 0.0002
610 EMBOLISM 2 0.0002
611 LIP SWELLING 8 0.0002
612 CONGESTIVE CARDIOMYOPATHY 1 0.0002
613 LIVE BIRTH 2 0.0002
614 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
615 INFUSION SITE ERYTHEMA 2 0.0002
616 HALLUCINATION, VISUAL 5 0.0002
617 RETCHING 5 0.0002
618 PSEUDOMONAS INFECTION 2 0.0002
619 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
620 ANURIA 2 0.0002
621 BLOOD MAGNESIUM DECREASED 2 0.0002
622 PSYCHOLOGICAL TRAUMA 2 0.0002
623 PYELONEPHRITIS 2 0.0002
624 PLATELET COUNT INCREASED 3 0.0002
625 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
626 ANHEDONIA 6 0.0002
627 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
628 WRONG DRUG ADMINISTERED 2 0.0002
629 PRODUCT USE IN UNAPPROVED INDICATION 55 0.0002
630 PYREXIA 76 0.0002
631 HYPERGLYCAEMIA 8 0.0002
632 ACUTE HEPATIC FAILURE 3 0.0002
633 ABDOMINAL HERNIA 1 0.0002
634 PNEUMONIA BACTERIAL 2 0.0002
635 OVERDOSE 47 0.0002
636 ACUTE KIDNEY INJURY 33 0.0002
637 AGRANULOCYTOSIS 4 0.0002
638 DEFORMITY 2 0.0002
639 CARDIAC TAMPONADE 1 0.0002
640 PARALYSIS 3 0.0002
641 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
642 DRUG PRESCRIBING ERROR 4 0.0002
643 APHAGIA 1 0.0002
644 PRESCRIBED OVERDOSE 4 0.0002
645 HYPOKINESIA 3 0.0002
646 PARKINSONISM 2 0.0002
647 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
648 ASCITES 6 0.0002
649 BREATH SOUNDS ABNORMAL 1 0.0002
650 ABNORMAL BEHAVIOUR 8 0.0002
651 OVARIAN CYST 2 0.0002
652 SALIVARY HYPERSECRETION 2 0.0002
653 AGGRESSION 10 0.0002
654 URINARY TRACT INFECTION 34 0.0002
655 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
656 FEEDING DISORDER 4 0.0002
657 DRUG DISPENSING ERROR 3 0.0002
658 MOTOR DYSFUNCTION 2 0.0002
659 NEUTROPHIL COUNT INCREASED 2 0.0002
660 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
661 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
662 EYE DISCHARGE 2 0.0002
663 PRODUCT USE ISSUE 36 0.0002
664 APLASTIC ANAEMIA 1 0.0002
665 FOLLICULITIS 2 0.0002
666 DISEASE RECURRENCE 9 0.0002
667 DYSARTHRIA 7 0.0002
668 ANAL ABSCESS 1 0.0002
669 INFUSION RELATED REACTION 12 0.0002
670 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
671 CYTOMEGALOVIRUS INFECTION 3 0.0002
672 SKIN INFECTION 2 0.0002
673 INTESTINAL PERFORATION 2 0.0002
674 NEPHROPATHY TOXIC 2 0.0002
675 NO ADVERSE EVENT 32 0.0002
676 SCAB 2 0.0002
677 HAEMATURIA 6 0.0002
678 MYOCARDITIS 2 0.0002
679 NEPHROLITHIASIS 8 0.0002
680 POST PROCEDURAL HAEMORRHAGE 2 0.0002
681 CAESAREAN SECTION 2 0.0002
682 VASCULITIS 2 0.0002
683 METASTASES TO LIVER 3 0.0002
684 LYMPHOCYTE COUNT DECREASED 3 0.0002
685 ACUTE MYOCARDIAL INFARCTION 5 0.0002
686 DEEP VEIN THROMBOSIS 11 0.0002
687 PLATELET COUNT DECREASED 18 0.0002
688 PRODUCT PRESCRIBING ERROR 4 0.0002
689 CARDIAC PACEMAKER INSERTION 1 0.0002
690 RASH ERYTHEMATOUS 8 0.0002
691 MUSCLE RIGIDITY 2 0.0002
692 RESPIRATORY DISORDER 5 0.0002
693 IRRITABILITY 10 0.0002
694 SUICIDE ATTEMPT 10 0.0002
695 C-REACTIVE PROTEIN INCREASED 6 0.0002
696 INJECTION SITE EXTRAVASATION 2 0.0002
697 HYPERCALCAEMIA 2 0.0002
698 SEPSIS 18 0.0002
699 BACTERIAL INFECTION 3 0.0002
700 SWOLLEN TONGUE 5 0.0002
701 HEPATIC CIRRHOSIS 3 0.0002
702 MOVEMENT DISORDER 5 0.0002
703 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
704 BLOOD CREATININE INCREASED 10 0.0002
705 TINNITUS 7 0.0002
706 SKIN DISCOLOURATION 7 0.0002
707 IMMUNE SYSTEM DISORDER 2 0.0002
708 DISORIENTATION 6 0.0002
709 PANCREATITIS 8 0.0002
710 EYE HAEMORRHAGE 2 0.0001
711 JAUNDICE 4 0.0001
712 PLEURAL EFFUSION 9 0.0001
713 TACHYPNOEA 2 0.0001
714 DRUG TOXICITY 2 0.0001
715 HAEMOGLOBIN DECREASED 15 0.0001
716 HALLUCINATION 11 0.0001
717 PERIPHERAL COLDNESS 2 0.0001
718 PULMONARY HYPERTENSION 3 0.0001
719 DISEASE PROGRESSION 17 0.0001
720 COORDINATION ABNORMAL 2 0.0001
721 OXYGEN SATURATION DECREASED 8 0.0001
722 OSTEOARTHRITIS 6 0.0001
723 DIVERTICULUM 1 0.0001
724 LOSS OF CONSCIOUSNESS 18 0.0001
725 INTENTIONAL OVERDOSE 9 0.0001
726 RED BLOOD CELL COUNT DECREASED 4 0.0001
727 SOMNOLENCE 28 0.0001
728 ARTHROPOD BITE 1 0.0001
729 TRANSAMINASES INCREASED 3 0.0001
730 CONDITION AGGRAVATED 41 0.0001
731 PULMONARY MASS 2 0.0001
732 ORAL PAIN 3 0.0001
733 SPEECH DISORDER 7 0.0001
734 PANCREATITIS ACUTE 3 0.0001
735 AORTIC ANEURYSM 1 0.0001
736 DEVICE FAILURE 2 0.0001
737 LIMB DISCOMFORT 4 0.0001
738 APHTHOUS ULCER 1 0.0001
739 EJECTION FRACTION DECREASED 2 0.0001
740 NERVOUS SYSTEM DISORDER 4 0.0001
741 INJURY 9 0.0001
742 HAEMATOCHEZIA 7 0.0001
743 PNEUMONIA 41 0.0001
744 HALLUCINATION, AUDITORY 2 0.0001
745 RASH 54 0.0001
746 BLOOD POTASSIUM INCREASED 2 0.0001
747 NEUTROPHIL COUNT DECREASED 5 0.0001
748 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
749 VISUAL ACUITY REDUCED 4 0.0001
750 COMPLETED SUICIDE 10 0.0001
751 SKIN DISORDER 4 0.0001
752 ATRIAL SEPTAL DEFECT 1 0.0001
753 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
754 FACE OEDEMA 2 0.0001
755 CANDIDA INFECTION 2 0.0001
756 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
757 CONFUSIONAL STATE 19 0.0001
758 HEPATITIS 3 0.0001
759 CARDIAC MURMUR 1 0.0001
760 LOCAL SWELLING 2 0.0001
761 HEART RATE DECREASED 4 0.0001
762 LYMPHADENOPATHY 4 0.0001
763 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
764 FEAR 3 0.0001
765 ANAL INCONTINENCE 1 0.0001
766 OSTEOMYELITIS 2 0.0001
767 DRUG EFFECT INCOMPLETE 4 0.0001
768 ERYTHEMA 22 0.0001
769 ABORTION INDUCED 1 0.0001
770 DYSPHAGIA 10 0.0001
771 PULMONARY EMBOLISM 10 0.0001
772 PROTEINURIA 2 0.0001
773 SLEEP APNOEA SYNDROME 2 0.0001
774 AFFECT LABILITY 1 0.0001
775 LIVER FUNCTION TEST ABNORMAL 3 0.0001
776 DYSTONIA 2 0.0001
777 AUTOIMMUNE DISORDER 1 0.0001
778 BODY TEMPERATURE DECREASED 1 0.0001
779 URINARY INCONTINENCE 3 0.0001
780 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
781 BLADDER DISORDER 1 0.0001
782 PRESCRIBED UNDERDOSE 2 0.0001
783 LEUKOPENIA 5 0.0001
784 BLOOD POTASSIUM DECREASED 3 0.0001
785 CARDIAC FAILURE CONGESTIVE 8 0.0001
786 HYPERTENSION 21 0.0001
787 PRODUCT ADMINISTRATION ERROR 2 0.0001
788 BONE MARROW FAILURE 2 0.0001
789 BLINDNESS 4 0.0001
790 DRUG ADMINISTRATION ERROR 3 0.0001
791 PRODUCT PREPARATION ERROR 2 0.0001
792 RIB FRACTURE 2 0.0001
793 COVID-19 17 0.0001
794 ABDOMINAL DISTENSION 10 0.0001
795 WITHDRAWAL SYNDROME 4 0.0001
796 LIVER FUNCTION TEST INCREASED 2 0.0001
797 BREAST CANCER METASTATIC 1 0.0001
798 DISTURBANCE IN ATTENTION 5 0.0001
799 DECREASED ACTIVITY 1 0.0001
800 OEDEMA 5 0.0001
801 SWELLING FACE 6 0.0001
802 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
803 IMPAIRED HEALING 3 0.0001
804 VIRAL INFECTION 3 0.0001
805 PULMONARY OEDEMA 4 0.0001
806 ANAEMIA 17 0.0001
807 CHOLECYSTECTOMY 1 0.0001
808 MUSCLE TWITCHING 2 0.0001
809 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
810 CEREBROVASCULAR ACCIDENT 14 0.0001
811 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
812 CRYING 3 0.0001
813 HYPOGLYCAEMIA 4 0.0001
814 ABASIA 2 0.0001
815 OSTEONECROSIS OF JAW 2 0.0001
816 CYST 1 0.0001
817 CARDIOVASCULAR DISORDER 2 0.0001
818 HYPOPHAGIA 2 0.0001
819 RESPIRATORY TRACT INFECTION 2 0.0001
820 MUCOSAL INFLAMMATION 2 0.0001
821 MUSCULOSKELETAL PAIN 4 0.0001
822 BEDRIDDEN 1 0.0001
823 INFECTION 11 0.0001
824 EMOTIONAL DISTRESS 9 0.0001
825 DRUG EFFECT DECREASED 4 0.0001
826 PNEUMONITIS 2 0.0001
827 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
828 WOUND 2 0.0001
829 SKIN EXFOLIATION 6 0.0001
830 BLINDNESS UNILATERAL 1 0.0001
831 EYE PAIN 4 0.0001
832 MUSCLE SPASMS 13 0.0001
833 MUSCULAR WEAKNESS 8 0.0001
834 MOBILITY DECREASED 5 0.0001
835 ACCIDENTAL UNDERDOSE 1 0.0001
836 BALANCE DISORDER 6 0.0001
837 MENTAL DISORDER 3 0.0001
838 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
839 UNDERDOSE 5 0.0001
840 PSYCHOTIC DISORDER 2 0.0001
841 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
842 COLON CANCER 1 0.0001
843 NEUTROPENIA 9 0.0001
844 THERAPEUTIC RESPONSE DECREASED 4 0.0001
845 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
846 EMOTIONAL DISORDER 2 0.0001
847 RENAL DISORDER 3 0.0001
848 BRAIN FOG 1 0.0001
849 CYANOSIS 1 0.0001
850 HEAD INJURY 2 0.0001
851 CYSTITIS 2 0.0001
852 HYPOTHYROIDISM 2 0.0001
853 CARDIAC FAILURE 5 0.0001
854 VOMITING 29 0.0001
855 ATRIAL FIBRILLATION 6 0.0001
856 AMNESIA 4 0.0001
857 LUNG DISORDER 3 0.0001
858 FUNGAL INFECTION 2 0.0001
859 PRURITUS 23 0.0001
860 GAIT INABILITY 2 0.0001
861 ANXIETY 17 0.0001
862 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
863 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
864 BLOOD GLUCOSE INCREASED 11 0.0001
865 AMENORRHOEA 1 0.0001
866 DRUG WITHDRAWAL SYNDROME 5 0.0001
867 SLEEP DISORDER 4 0.0001
868 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
869 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
870 BONE DISORDER 1 0.0001
871 TREMOR 9 0.0001
872 BRONCHITIS 4 0.0001
873 URTICARIA 9 0.0001
874 NECK PAIN 3 0.0001
875 CARDIAC DISORDER 5 0.0001
876 BLOOD SODIUM DECREASED 1 0.0001
877 BLOOD URINE PRESENT 1 0.0001
878 CYTOKINE RELEASE SYNDROME 1 0.0000
879 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
880 STOMATITIS 3 0.0000
881 EXTRA DOSE ADMINISTERED 2 0.0000
882 BODY TEMPERATURE INCREASED 1 0.0000
883 DEPRESSION 11 0.0000
884 HAEMORRHAGE 5 0.0000
885 GAIT DISTURBANCE 9 0.0000
886 RECTAL HAEMORRHAGE 2 0.0000
887 CONSTIPATION 10 0.0000
888 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
889 HOSPITALISATION 7 0.0000
890 DEHYDRATION 6 0.0000
891 PARAESTHESIA 7 0.0000
892 INCORRECT DOSE ADMINISTERED 10 0.0000
893 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
894 MEMORY IMPAIRMENT 6 0.0000
895 CHEST PAIN 8 0.0000
896 SWELLING 4 0.0000
897 OCULAR HYPERAEMIA 2 0.0000
898 NEUROPATHY PERIPHERAL 4 0.0000
899 THERAPY INTERRUPTED 3 0.0000
900 PRODUCTIVE COUGH 2 0.0000
901 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
902 DIABETIC KETOACIDOSIS 1 0.0000
903 OEDEMA PERIPHERAL 5 0.0000
904 SYNCOPE 4 0.0000
905 CELLULITIS 2 0.0000
906 UNEVALUABLE EVENT 3 0.0000
907 INJECTION SITE SWELLING 3 0.0000
908 FALL 13 0.0000
909 ANAPHYLACTIC SHOCK 1 0.0000
910 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
911 DEAFNESS 1 0.0000
912 RASH PRURITIC 2 0.0000
913 VISION BLURRED 5 0.0000
914 ANAPHYLACTIC REACTION 2 0.0000
915 DIVERTICULITIS 1 0.0000
916 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
917 PAIN 22 0.0000
918 NAUSEA 28 0.0000
919 DYSPNOEA 20 0.0000
920 ANGINA PECTORIS 1 0.0000
921 ASTHENIA 13 0.0000
922 DECREASED APPETITE 8 0.0000
923 BACK PAIN 8 0.0000
924 DYSSTASIA 1 0.0000
925 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
926 MUSCULOSKELETAL STIFFNESS 3 0.0000
927 SURGERY 2 0.0000
928 DIZZINESS 17 0.0000
929 WHEEZING 2 0.0000
930 DEATH 29 0.0000
931 HEADACHE 21 0.0000
932 HYPOAESTHESIA 5 0.0000
933 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
934 ILL-DEFINED DISORDER 2 0.0000
935 DISCOMFORT 2 0.0000
936 ADVERSE EVENT 3 0.0000
937 VISUAL IMPAIRMENT 4 0.0000
938 BONE DENSITY DECREASED 1 0.0000
939 CONTUSION 3 0.0000
940 RHINORRHOEA 2 0.0000
941 HEART RATE INCREASED 3 0.0000
942 FEBRILE NEUTROPENIA 2 0.0000
943 NEOPLASM MALIGNANT 2 0.0000
944 ANGER 1 0.0000
945 CHEST DISCOMFORT 3 0.0000
946 DYSURIA 1 0.0000
947 HYPERSENSITIVITY 5 0.0000
948 EPISTAXIS 2 0.0000
949 DYSPNOEA EXERTIONAL 1 0.0000
950 HOT FLUSH 2 0.0000
951 INSOMNIA 7 0.0000
952 CHILLS 3 0.0000
953 COUGH 7 0.0000
954 THROMBOSIS 2 0.0000
955 DIARRHOEA 16 0.0000
956 DEVICE BREAKAGE 1 0.0000
957 HYPERHIDROSIS 3 0.0000
958 MYOCARDIAL INFARCTION 4 0.0000
959 DRY SKIN 3 0.0000
960 ADVERSE DRUG REACTION 2 0.0000
961 ABDOMINAL PAIN 5 0.0000
962 BLOOD CHOLESTEROL INCREASED 1 0.0000
963 DRUG INTOLERANCE 2 0.0000
964 PAIN IN EXTREMITY 6 0.0000
965 FLUSHING 2 0.0000
966 BLOOD PRESSURE INCREASED 3 0.0000
967 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
968 SINUSITIS 2 0.0000
969 FATIGUE 15 0.0000
970 DERMATITIS ATOPIC 1 0.0000
971 ARTHROPATHY 1 0.0000
972 BONE PAIN 1 0.0000
973 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
974 JOINT SWELLING 2 0.0000
975 BURNING SENSATION 1 0.0000
976 WEIGHT INCREASED 3 0.0000
977 CHRONIC KIDNEY DISEASE 1 0.0000
978 DIABETES MELLITUS 1 0.0000
979 PERIPHERAL SWELLING 2 0.0000
980 FEELING ABNORMAL 3 0.0000
981 DRUG DOSE OMISSION 2 0.0000
982 DRUG ABUSE 1 0.0000
983 ABDOMINAL DISCOMFORT 2 0.0000
984 MYALGIA 2 0.0000
985 MALAISE 5 0.0000
986 DEVICE ISSUE 1 0.0000
987 ABDOMINAL PAIN UPPER 2 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
989 ASTHMA 1 0.0000
990 INJECTION SITE PAIN 2 0.0000
991 ARTHRALGIA 2 0.0000